Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - NET INCOME
Net Income IKT - Inhibikase Therapeutics, Inc.
-27.5 M
LAST VALUE
-23.46%
2 YEAR CAGR
-36.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR